1.65
前日終値:
$1.69
開ける:
$1.68
24時間の取引高:
464.50K
Relative Volume:
0.67
時価総額:
$104.29M
収益:
$139.77M
当期純損益:
$-97.62M
株価収益率:
-1.0443
EPS:
-1.58
ネットキャッシュフロー:
$-61.71M
1週間 パフォーマンス:
-2.37%
1か月 パフォーマンス:
+7.84%
6か月 パフォーマンス:
+30.95%
1年 パフォーマンス:
-58.96%
Macrogenics Inc Stock (MGNX) Company Profile
名前
Macrogenics Inc
セクター
電話
301-251-5172
住所
9704 MEDICAL CENTER DRIVE, Rockville, MD
MGNX を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
MGNX
Macrogenics Inc
|
1.65 | 106.82M | 139.77M | -97.62M | -61.71M | -1.58 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
416.81 | 104.76B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
481.67 | 63.06B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
578.05 | 60.32B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
843.66 | 51.55B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
INSM
Insmed Inc
|
165.76 | 34.49B | 398.11M | -1.03B | -868.57M | -5.7032 |
Macrogenics Inc Stock (MGNX) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-09-17 | 再開されました | Barclays | Overweight |
2024-11-07 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
2024-08-01 | ダウングレード | BTIG Research | Buy → Neutral |
2024-07-31 | ダウングレード | B. Riley Securities | Buy → Neutral |
2024-07-31 | ダウングレード | Guggenheim | Buy → Neutral |
2024-05-10 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
2024-05-10 | ダウングレード | Stifel | Buy → Hold |
2024-05-10 | ダウングレード | TD Cowen | Buy → Hold |
2024-04-26 | 開始されました | B. Riley Securities | Buy |
2024-04-09 | アップグレード | TD Cowen | Hold → Buy |
2024-03-04 | 繰り返されました | BTIG Research | Buy |
2024-02-14 | ダウングレード | H.C. Wainwright | Buy → Neutral |
2023-12-20 | アップグレード | Citigroup | Neutral → Buy |
2023-11-07 | アップグレード | Guggenheim | Neutral → Buy |
2023-03-17 | ダウングレード | Guggenheim | Buy → Neutral |
2022-11-22 | ダウングレード | Cowen | Outperform → Market Perform |
2022-11-14 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
2022-07-18 | ダウングレード | SMBC Nikko | Outperform → Neutral |
2022-07-11 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
2022-05-04 | ダウングレード | Guggenheim | Buy → Neutral |
2022-02-28 | アップグレード | Citigroup | Neutral → Buy |
2022-02-11 | 開始されました | BMO Capital Markets | Outperform |
2022-02-04 | 開始されました | SMBC Nikko | Outperform |
2021-11-17 | 再開されました | Guggenheim | Buy |
2021-10-19 | 開始されました | JMP Securities | Mkt Outperform |
2021-10-15 | 再開されました | BTIG Research | Buy |
2021-04-26 | 再開されました | Credit Suisse | Outperform |
2021-03-12 | アップグレード | Barclays | Underweight → Overweight |
2020-12-22 | 再開されました | H.C. Wainwright | Buy |
2020-08-03 | ダウングレード | Citigroup | Buy → Neutral |
2020-06-01 | アップグレード | Guggenheim | Neutral → Buy |
2020-05-26 | 繰り返されました | H.C. Wainwright | Buy |
2020-03-04 | 開始されました | Barclays | Underweight |
2019-12-19 | 開始されました | Cantor Fitzgerald | Overweight |
2019-12-18 | 開始されました | Cantor Fitzgerald | Overweight |
2019-11-21 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
2019-11-20 | 再開されました | Guggenheim | Neutral |
2019-05-03 | アップグレード | Wedbush | Neutral → Outperform |
2019-04-12 | 開始されました | Guggenheim | Neutral |
2019-02-07 | アップグレード | Citigroup | Sell → Buy |
2019-02-07 | ダウングレード | Wedbush | Outperform → Neutral |
2019-02-06 | アップグレード | Raymond James | Underperform → Mkt Perform |
2019-02-04 | ダウングレード | Citigroup | Neutral → Sell |
2018-12-10 | ダウングレード | Raymond James | Outperform → Underperform |
2018-09-10 | 再開されました | BTIG Research | Buy |
2018-05-31 | 開始されました | Evercore ISI | Outperform |
2018-03-05 | 開始されました | H.C. Wainwright | Buy |
2017-03-31 | 開始されました | Raymond James | Outperform |
すべてを表示
Macrogenics Inc (MGNX) 最新ニュース
Will MacroGenics Inc. stock rally after Fed decisions2025 Top Gainers & High Accuracy Swing Trade Signals - newser.com
GE HealthCare Technologies (NASDAQ:GEHC) & MacroGenics (NASDAQ:MGNX) Critical Comparison - Defense World
Can MacroGenics Inc. stock hit record highs againJuly 2025 Institutional & Accurate Technical Buy Alerts - newser.com
Applying sector rotation models to MacroGenics Inc.Weekly Volume Report & Weekly Market Pulse Updates - newser.com
How MacroGenics Inc. stock performs in high volatility markets2025 Volume Leaders & Weekly Stock Performance Updates - newser.com
Chart based analysis of MacroGenics Inc. trends2025 Volume Leaders & Expert Curated Trade Ideas - newser.com
When is the best time to exit MacroGenics Inc.July 2025 Momentum & Low Risk High Reward Trade Ideas - newser.com
Applying Wyckoff theory to MacroGenics Inc. stock2025 Investor Takeaways & Daily Entry Point Trade Alerts - newser.com
Weiss Ratings Reaffirms Sell (E+) Rating for MacroGenics (NASDAQ:MGNX) - MarketBeat
Bispecific Antibodies MarketGlobal Forecast 2025-2032, Profiles of Key PlayersF. Hoffmann-La Roche, Amgen, Janssen Biotech, Pfizer, AbbVie, Regeneron, MacroGenics, AstraZeneca, Merck, and Genmab - Yahoo Finance
Public Employees Retirement System of Ohio Has $31,000 Stake in MacroGenics, Inc. $MGNX - Defense World
MacroGenics (NASDAQ:MGNX) and CeriBell (NASDAQ:CBLL) Head to Head Comparison - Defense World
MacroGenics, Inc. (NASDAQ:MGNX) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Regression analysis insights on MacroGenics Inc. performanceDay Trade & Weekly Market Pulse Updates - newser.com
Using data models to predict MacroGenics Inc. stock movementJuly 2025 Spike Watch & Low Risk Profit Maximizing Plans - newser.com
Published on: 2025-10-05 06:01:39 - newser.com
Backtesting results for MacroGenics Inc. trading strategies2025 EndofYear Setup & Daily Risk Controlled Trade Plans - newser.com
Multi asset correlation models including MacroGenics Inc.Quarterly Profit Review & Weekly Breakout Stock Alerts - newser.com
How currency fluctuations impact MacroGenics Inc. stockJuly 2025 Breakouts & Expert Approved Momentum Trade Ideas - newser.com
Developing predictive dashboards with MacroGenics Inc. dataWeekly Investment Report & Verified Entry Point Signals - newser.com
Published on: 2025-10-02 22:14:22 - newser.com
Voya Investment Management LLC Buys 40,500 Shares of MacroGenics, Inc. $MGNX - Defense World
Published on: 2025-09-30 05:12:41 - newser.com
What drives MacroGenics Inc stock priceCash Flow Trends & Amplify Gains With Picks - earlytimes.in
Goldman Sachs Group Inc. Has $251,000 Position in MacroGenics, Inc. $MGNX - MarketBeat
Extensive-Stage Small Cell Lung Cancer Pipeline 2025: Innovative Clinical Developments By 25+ Global Leaders Delveinsight Key Companies Featured Include Shanghai Henlius Biotech, Macrogenics, Inc. - Menafn.com
What drives PROG Holdings Inc AZD stock priceInterest Rate Changes & Small Capital Wealth Plans - earlytimes.in
*DJ Macrogenics Announces Removal of Partial Clinical Hold on MGD009 Program by FDA >MGNX - 富途牛牛
Strs Ohio Invests $263,000 in MacroGenics, Inc. $MGNX - MarketBeat
Intraday pattern recognizer results for MacroGenics Inc.July 2025 PostEarnings & Real-Time Volume Analysis - newser.com
Statistical indicators supporting MacroGenics Inc.’s strengthIPO Watch & Accurate Entry and Exit Point Alerts - newser.com
Published on: 2025-09-22 05:42:18 - newser.com
Barclays Upgrades MacroGenics (NASDAQ:MGNX) to "Strong-Buy" - MarketBeat
MacroGenics (NASDAQ:MGNX) Now Covered by Analysts at Barclays - MarketBeat
Acadian Asset Management LLC Grows Position in MacroGenics, Inc. $MGNX - MarketBeat
Live market analysis of MacroGenics Inc.Quarterly Market Summary & Safe Capital Allocation Plans - newser.com
What institutional flow reveals about MacroGenics Inc.July 2025 Drop Watch & Capital Efficient Trade Techniques - newser.com
Macrogenics Inc (MGNX) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):